AzTrials
AzTrials

Amputees / RehabilitationEQUIL-ARCNCT06424249

Dynamic Balance in Unilateral Transtibial Amputees Following Virtual Reality Versus Conventional Rehabilitation

A study testing Virtual Reality and Standard rehabilitation in people with Amputees / Rehabilitation and Virtual Reality, run by Centre Hospitalier Universitaire de Nīmes at 2 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Amputation causes somatic and psychological damage. Prognostic factors for postoperative gait recovery include the need for proprioceptive re-education for dynamic balance. Improved gait patterns and use of the prosthesis contribute to an overall improvement in the amputee's autonomy. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
Virtual Reality and Standard rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
2 sitesFrance
Study dates
14 Oct 2024to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Unilateral transtibial amputees in hospitalized in the rehabilitation of the musculoskeletal system service
  • All etiologies: vascular, traumatic and septic.
  • Adapted vascular equipment validated by physician.
  • Able to walk for 5 minutes on a treadmill without technical assistance.
  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan

Who cannot join

  • The subject is participating in an interventional study or one involving a drug or medical device, or is in a period of exclusion determined by a previous study
  • Patient already included in the present study.
  • The subject refuses to or is unable to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • Patients with uncorrected or untreated visual disorders.
Show all 25Show fewer
  • Patients with major cognitive disorders (MOCA>23).
  • Patients with vestibular disorders.
  • Patient with uncontrolled epilepsy.
  • Patient with an unhealed amputation stump.
  • Patients weighing > 135kg or < 20kg.
  • Patients with a functional ambulation category of 1 (i.e. patients requiring the firm, continuous assistance of another person to carry their weight and maintain their balance) or less.
  • Patients with medication affecting exercise tolerance,
  • Patients with sensory impairments
  • Patients with significantly reduced bone density
  • Patients for whom it is impossible to correctly adjust the harness to the corresponding body part due to:
  • Body shape
  • Colostomy bags
  • Skin lesions that cannot be adequately protected.
  • Any other reason that prevents proper, pain-free adjustment of the sling.
  • Pregnant, parturient or breast-feeding patients.
  • Appearance of a stump wound during the study requiring discharge.
  • Patient with more than 50% absenteeism from rehabilitation sessions.
  • Patient requiring a new prosthesis insert.
  • Patient with a serious adverse event affecting dynamic balance rehabilitation.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

France2 sites, 2 recruiting
  • CHU de Nîmes, Hôpital du Grau du Roi

    Le Grau-du-Roi, 30240

    Eric PANTERA, MD

    Recruiting
  • CHU de Nimes

    Nîmes

    Anissa Megzari, 04.66.68.42.36, drc@chu-nimes.fr

    Eric Pantera

    Not yet recruiting

Other trials in France

About this study

Amputation causes somatic and psychological damage. Prognostic factors for postoperative gait recovery include the need for proprioceptive re-education for dynamic balance. Improved gait patterns and use of the prosthesis contribute to an overall improvement in the amputee's autonomy. Virtual reality coupled with movement analysis allows personalization of treatment with objective assessment of progress.

The study authors hypothesize that a virtual reality protocol for the dynamic balance of a unilateral transtibial amputee in initial rehabilitation will improve the dynamic balance assessment criteria compared with a conventional rehabilitation protocol.

Being tested
Virtual Reality, Standard rehabilitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual RealityOther

    A progressive rehabilitation protocol (different levels according to success scores) consisting of several exercises using virtual and augmented reality with mechanical perturbations (pitching of the treadmill), interaction with the virtual environment, interaction with the virtual environment and augmented reality (projection of obstacles on the treadmill), and modification of the gait pattern with visual and/or audio biofeedback

  • Standard rehabilitationOther

    A treadmill walking protocol with virtual reality to immerse the patient in a 3 x 5-minute walking session, without visual, mechanical or auditory disturbances, and without prompting the patient to modify their walking pattern.

Study groups in NCT06424249
Study groupRoleWhat they receive
Virtual Reality groupExperimentalNot described
Receives: Other: Virtual Reality
Control groupActive comparatorNot described
Receives: Other: Standard rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mediolateral instability during mediolateral external perturbation between groups

    The number of gait cycles required to regain center of mass displacement (number of cycles * cycle time), measured with the GRAIL rehabilitation and movement analysis platform

    Measured: Before rehabilitation (Day 1)

  2. Mediolateral instability during mediolateral external perturbation between groups

    The number of gait cycles required to regain center of mass displacement (number of cycles * cycle time), measured with the GRAIL rehabilitation and movement analysis platform

    Measured: End of rehabilitation sessions (Day 45)

Secondary outcomes (14)
  1. Step length variability between groups

    Meters, measured with the GRAIL rehabilitation and movement analysis platform

    Measured: Before rehabilitation (Day 1)

  2. Step length variability between groups

    Meters, measured with the GRAIL rehabilitation and movement analysis platform

    Measured: End of rehabilitation sessions (Day 45)

  3. Step width variability between groups

    Meters, measured with the GRAIL rehabilitation and movement analysis platform

    Measured: Before rehabilitation (Day 1)

  4. Step width variability between groups

    Meters, measured with the GRAIL rehabilitation and movement analysis platform

    Measured: End of rehabilitation sessions (Day 45)

  5. Cadence variability between groups

    Steps/minute, measured with the GRAIL rehabilitation and movement analysis platform

    Measured: Before rehabilitation (Day 1)

  6. Cadence variability between groups

    Steps/minute, measured with the GRAIL rehabilitation and movement analysis platform

    Measured: End of rehabilitation sessions (Day 45)

  7. Center of mass variability between groups

    Meters, measured with the GRAIL rehabilitation and movement analysis platform

    Measured: Before rehabilitation (Day 1)

  8. Center of mass variability between groups

    Meters, measured with the GRAIL rehabilitation and movement analysis platform

    Measured: End of rehabilitation sessions (Day 45)

  9. Mobility and balance between groups

    Time Up and Go test, seconds

    Measured: Before rehabilitation (Day 1)

  10. Mobility and balance between groups

    Time Up and Go test, seconds

    Measured: End of rehabilitation sessions (Day 45)

  11. Aerobic endurance and functional capacity between groups

    2-minute walk test, meters

    Measured: Before rehabilitation (Day 1)

  12. Aerobic endurance and functional capacity between groups

    2-minute walk test, meters

    Measured: End of rehabilitation sessions (Day 45)

  13. Fall risk between groups

    Berg scale, score between 0 and 56 (no fall risk)

    Measured: Before rehabilitation (Day 1)

  14. Fall risk between groups

    Berg scale, score between 0 and 56 (no fall risk)

    Measured: End of rehabilitation sessions (Day 45)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2024
  2. Study start14 Oct 2024
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06424249
Sponsor's protocol ID
Local/2023/EP-02
Acronym
EQUIL-ARC
Status last verified
Jun 2026
First submitted
16 May 2024
Last updated
25 Jun 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality and Standard rehabilitation in people with Amputees / Rehabilitation and Virtual Reality, run by Centre Hospitalier Universitaire de Nīmes at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 25 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eric Pantera (04 66 02 25 36, eric.pantera@chu-nimes.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mediolateral instability during mediolateral external perturbation between groups (time frame: Before rehabilitation (Day 1)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in